Home > Category > > Small Molecule Compound > Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂

Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂

Glpbio

Catalog No：GA23179-5mg CAS No.：720710-69-0 MDLNo： Brand:Glpbio purity： 特性： Purpose:The N-terminal elongation of the widely used MMP FRET substrate Mca-PLGL-Dpa-AR-NH? (M-1895) with a Lys yields a fluorogenic peptide with improved substrate properties. As compared to M-1895, the specificity constant (kcat/Km) of the broad-spectrum MMP-substrate M-2350, Mca-KPLGL-Dpa-AR-NH? for collagenases (MMP-1, MMP-8, MMP-13) and MMP-14 is increased two- to ninefold and threefold, respectively, while those for gelatinases and matrilysin remain equally high.Soluble in DMSO

Share

Size	Availability	Price(USD)
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂
CAS	720710-69-0
Formula	C₅₅H₈₀N₁₆O₁₆
MW	1221.34
Storage condition	Store at -20°C

Related literature

Sorry, there is no relevant literature

Related

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

History

Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂

Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂

METADHERIN (C-TERM) REC RBT MO

METADHERIN (C-TERM) REC RBT MO

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

NA ≥95%,99%e.e.

IL-17F REC RBT MONO AB

IL-17F REC RBT MONO AB

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

1297613-73-0 ≥98%,99%e.e.

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

1345628-08-1 ≥98%,99%e.e.

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

NA ≥95%,99%e.e.